Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI: C treatment

Taku Nagai, Yuko Kitahara, Daisuke Ibi, Toshitaka Nabeshima, Akira Sawa, Kiyofumi Yamada

Research output: Contribution to journalArticle

Abstract

Interactions of environmental and genetic factors may play a role in the pathoetiology of schizophrenia. We have recently developed a novel animal model of mental disorders such as schizophrenia by inducing abnormal immune response during the perinatal period in mice with overexpression of the human dominant-negative form of disrupted-in-schizophrenia 1 (DN-DISC1). In the present study, we investigated the effects of antipsychotics on the behavioral deficits in this animal model for mental disorders with gene-environment interaction. Neonatal DN-DISC1 transgenic (DN-DISC1 tg) mice were repeatedly injected with polyriboinosinic-polyribocytidylic acid (polyI:C) for 5 days from postnatal days 2 to 6. The behavioral analyses were performed in adulthood. Clozapine (3. mg/kg) or haloperidol (1. mg/kg) was administered orally once a day from 1 week before starting a series of behavioral experiments and continued until the end of the study. Cognitive impairment in polyI:C-treated DN-DISC1 tg mice was improved by repeated administration of clozapine while haloperidol had no effect. Both antipsychotics suppressed the augmentation of MK-801-induced hyperactivity in the model mice. Neither clozapine nor haloperidol ameliorated the impairments of social behaviors in polyI:C-treated DN-DISC1 tg mice. These results suggest that the polyI:C-treated DN-DISC tg mice are quite unique as an animal model for mental disorders. Furthermore, this mouse model may be useful for the screening of potential antipsychotic compounds that could be more effective than clozapine in ameliorating negative symptoms and cognitive impairment in schizophrenia.

Original languageEnglish (US)
Pages (from-to)305-310
Number of pages6
JournalBehavioural Brain Research
Volume225
Issue number1
DOIs
StatePublished - Nov 20 2011

Fingerprint

Transgenic Mice
Antipsychotic Agents
Schizophrenia
Clozapine
Haloperidol
Mental Disorders
Animal Models
Acids
Gene-Environment Interaction
Dizocilpine Maleate
Social Behavior

Keywords

  • DISC1
  • Gene-environment interaction
  • PolyI:C, Susceptibility gene
  • Schizophrenia
  • Transgenic mice
  • Viral infection

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI : C treatment. / Nagai, Taku; Kitahara, Yuko; Ibi, Daisuke; Nabeshima, Toshitaka; Sawa, Akira; Yamada, Kiyofumi.

In: Behavioural Brain Research, Vol. 225, No. 1, 20.11.2011, p. 305-310.

Research output: Contribution to journalArticle

Nagai, Taku ; Kitahara, Yuko ; Ibi, Daisuke ; Nabeshima, Toshitaka ; Sawa, Akira ; Yamada, Kiyofumi. / Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI : C treatment. In: Behavioural Brain Research. 2011 ; Vol. 225, No. 1. pp. 305-310.
@article{3024588bd32e42a4bdba44263e6e1f70,
title = "Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI: C treatment",
abstract = "Interactions of environmental and genetic factors may play a role in the pathoetiology of schizophrenia. We have recently developed a novel animal model of mental disorders such as schizophrenia by inducing abnormal immune response during the perinatal period in mice with overexpression of the human dominant-negative form of disrupted-in-schizophrenia 1 (DN-DISC1). In the present study, we investigated the effects of antipsychotics on the behavioral deficits in this animal model for mental disorders with gene-environment interaction. Neonatal DN-DISC1 transgenic (DN-DISC1 tg) mice were repeatedly injected with polyriboinosinic-polyribocytidylic acid (polyI:C) for 5 days from postnatal days 2 to 6. The behavioral analyses were performed in adulthood. Clozapine (3. mg/kg) or haloperidol (1. mg/kg) was administered orally once a day from 1 week before starting a series of behavioral experiments and continued until the end of the study. Cognitive impairment in polyI:C-treated DN-DISC1 tg mice was improved by repeated administration of clozapine while haloperidol had no effect. Both antipsychotics suppressed the augmentation of MK-801-induced hyperactivity in the model mice. Neither clozapine nor haloperidol ameliorated the impairments of social behaviors in polyI:C-treated DN-DISC1 tg mice. These results suggest that the polyI:C-treated DN-DISC tg mice are quite unique as an animal model for mental disorders. Furthermore, this mouse model may be useful for the screening of potential antipsychotic compounds that could be more effective than clozapine in ameliorating negative symptoms and cognitive impairment in schizophrenia.",
keywords = "DISC1, Gene-environment interaction, PolyI:C, Susceptibility gene, Schizophrenia, Transgenic mice, Viral infection",
author = "Taku Nagai and Yuko Kitahara and Daisuke Ibi and Toshitaka Nabeshima and Akira Sawa and Kiyofumi Yamada",
year = "2011",
month = "11",
day = "20",
doi = "10.1016/j.bbr.2011.07.049",
language = "English (US)",
volume = "225",
pages = "305--310",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI

T2 - C treatment

AU - Nagai, Taku

AU - Kitahara, Yuko

AU - Ibi, Daisuke

AU - Nabeshima, Toshitaka

AU - Sawa, Akira

AU - Yamada, Kiyofumi

PY - 2011/11/20

Y1 - 2011/11/20

N2 - Interactions of environmental and genetic factors may play a role in the pathoetiology of schizophrenia. We have recently developed a novel animal model of mental disorders such as schizophrenia by inducing abnormal immune response during the perinatal period in mice with overexpression of the human dominant-negative form of disrupted-in-schizophrenia 1 (DN-DISC1). In the present study, we investigated the effects of antipsychotics on the behavioral deficits in this animal model for mental disorders with gene-environment interaction. Neonatal DN-DISC1 transgenic (DN-DISC1 tg) mice were repeatedly injected with polyriboinosinic-polyribocytidylic acid (polyI:C) for 5 days from postnatal days 2 to 6. The behavioral analyses were performed in adulthood. Clozapine (3. mg/kg) or haloperidol (1. mg/kg) was administered orally once a day from 1 week before starting a series of behavioral experiments and continued until the end of the study. Cognitive impairment in polyI:C-treated DN-DISC1 tg mice was improved by repeated administration of clozapine while haloperidol had no effect. Both antipsychotics suppressed the augmentation of MK-801-induced hyperactivity in the model mice. Neither clozapine nor haloperidol ameliorated the impairments of social behaviors in polyI:C-treated DN-DISC1 tg mice. These results suggest that the polyI:C-treated DN-DISC tg mice are quite unique as an animal model for mental disorders. Furthermore, this mouse model may be useful for the screening of potential antipsychotic compounds that could be more effective than clozapine in ameliorating negative symptoms and cognitive impairment in schizophrenia.

AB - Interactions of environmental and genetic factors may play a role in the pathoetiology of schizophrenia. We have recently developed a novel animal model of mental disorders such as schizophrenia by inducing abnormal immune response during the perinatal period in mice with overexpression of the human dominant-negative form of disrupted-in-schizophrenia 1 (DN-DISC1). In the present study, we investigated the effects of antipsychotics on the behavioral deficits in this animal model for mental disorders with gene-environment interaction. Neonatal DN-DISC1 transgenic (DN-DISC1 tg) mice were repeatedly injected with polyriboinosinic-polyribocytidylic acid (polyI:C) for 5 days from postnatal days 2 to 6. The behavioral analyses were performed in adulthood. Clozapine (3. mg/kg) or haloperidol (1. mg/kg) was administered orally once a day from 1 week before starting a series of behavioral experiments and continued until the end of the study. Cognitive impairment in polyI:C-treated DN-DISC1 tg mice was improved by repeated administration of clozapine while haloperidol had no effect. Both antipsychotics suppressed the augmentation of MK-801-induced hyperactivity in the model mice. Neither clozapine nor haloperidol ameliorated the impairments of social behaviors in polyI:C-treated DN-DISC1 tg mice. These results suggest that the polyI:C-treated DN-DISC tg mice are quite unique as an animal model for mental disorders. Furthermore, this mouse model may be useful for the screening of potential antipsychotic compounds that could be more effective than clozapine in ameliorating negative symptoms and cognitive impairment in schizophrenia.

KW - DISC1

KW - Gene-environment interaction

KW - PolyI:C, Susceptibility gene

KW - Schizophrenia

KW - Transgenic mice

KW - Viral infection

UR - http://www.scopus.com/inward/record.url?scp=80052023997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052023997&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2011.07.049

DO - 10.1016/j.bbr.2011.07.049

M3 - Article

C2 - 21835207

AN - SCOPUS:80052023997

VL - 225

SP - 305

EP - 310

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 1

ER -